Literature DB >> 8852964

Editorial response: catheters and candidemia.

J H Rex.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852964     DOI: 10.1093/clinids/22.3.467

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  Candida famata fungemia in a surgical patient successfully treated with fluconazole.

Authors:  G Carrega; G Riccio; L Santoriello; M Pasqualini; R Pellicci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

2.  Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.

Authors:  Russell E Lewis; Dimitrios P Kontoyiannis; Rabih O Darouiche; Issam I Raad; Randall A Prince
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  Assessment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease.

Authors:  C Girmenia; P Martino; F De Bernardis; A Cassone
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  Electrophoretic karyotype analysis of sequential Candida parapsilosis isolates from patients with persistent or pecurrent fungemia.

Authors:  J H Shin; D H Shin; J W Song; S J Kee; S P Suh; D W Ryang
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

Review 5.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents.

Authors:  Si-Hyun Kim; Jae-Ki Choi; Sung-Yeon Cho; Hyo-Jin Lee; Sun Hee Park; Su-Mi Choi; Dong-Gun Lee; Jung-Hyun Choi; Jin-Hong Yoo; Jong-Wook Lee
Journal:  Med Mycol       Date:  2018-02-01       Impact factor: 4.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.